Welcome to PharML, a workshop where we explore the role of machine learning and artificial intelligence in unraveling the complexities of disease mechanisms.
This is the 6th. iteration of PharML at ECML-PKDD. Dive into the history of our past meetings (2020, 2021, 2022, 2023, 2025) and join us this year as we continue to push the boundaries of innovation and discovery in machine learning for pharma and healthcare.Â
The journey of drug development is intricate, involving numerous stages where vast amounts of valuable data are amassed during clinical trials. This data holds the key to discovering potential treatment targets, identifying new biomarkers, and determining which patients are most likely to benefit from specific treatments. Moreover, it provides crucial insights into the safety and efficacy of therapies. Once a drug is launched, additional data is continuously generated from electronic medical records, disease registries, health insurance claims, surveys, and digital devices, among other sources.
The sheer volume and diversity of healthcare data have opened up exciting opportunities, albeit with significant challenges. The increasing use of these varied data sources calls for innovative approaches. Machine learning methodologies offer a powerful means to extract insights and facilitate learning from these complex datasets. These cutting-edge techniques have the potential to revolutionize medical practice, driving the development of personalized medicines.
Join us at PharML, where leading experts from industry and academia will converge to share their pioneering research and experiences in harnessing machine learning and artificial intelligence for pharmaceutical and healthcare R&D. This is your chance to be at the forefront of a new era in healthcare innovation.